HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Will the new target-specific oral anticoagulants improve the treatment of venous thromboembolism?

AuthorsJack Ansell
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 107 Issue 6 Pg. 1009-11 (Jun 2012) ISSN: 2567-689X [Electronic] Germany
PMID22437129 (Publication Type: Editorial, Comment)
Chemical References
  • Anticoagulants
  • Morpholines
  • Thiophenes
  • Rivaroxaban
Topics
  • Anticoagulants (administration & dosage)
  • Female
  • Humans
  • Male
  • Morpholines (administration & dosage)
  • Rivaroxaban
  • Thiophenes (administration & dosage)
  • Venous Thromboembolism (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: